The in Vivo and in Vitro Effect of Antihistamines on Platelet Aggregation

Summary

The effect of antihistamines on platelet aggregation was studied by examining the platelet rich plasma of subjects taking three representative classes of these drugs, as well as by studying the effect of direct addition of antihistamine to platelet rich plasma. Inhibition of aggregation by in vitro addition was obtained only with drug concentrations much greater than would usually be found in vivo. Platelet aggregation was unimpaired in normal volunteers taking standard doses of antihistamines.

• References

• 1 Drach J. C, Howell J. P, Boeondy P. E, and Glazko A. J. 1970; Species differences in the metabolism of diphenhydramine (Benadryl). Proceedings of the Society for Experimental Biology and Medicine 135: 849.
• 2 Duemann R. G, and Frank V. D. 1966; Effect of adenosine derivatives and antihistamines on platelet aggregation. Proceedings of the Society for Experimental Biology and Medicine 123: 654.
• 3 Glazko A. J, and Dill W. A. 1949; Biochemical studies on diphenhydramine II. Distribution in tissues and urinary excretion. Journal of Biological Chemistry 179: 403.
• 4 Harrison M. J. G, Emmons P. R, and Mitchell J. R. A. 1967; The variability of human platelet aggregation. Journal of Atherosclerosis Research 7: 197.
• 5 Kinkel A. W. 1968; Physiological profile of drug action. Wisconsin Pharmacist 11: 396.
• 6 Mills D. C. B, and Roberts G. C. K. 1967; Membrane active drugs and aggregation of human platelets. Nature 213: 35.
• 7 O’Brien V. R. 1961; The adhesiveness of native platelets and its prevention. Journal of Clinical Pathology 14: 140.
• 8 Weiss H. J. 1972. The pharmacology of platelet inhibition. In: Spaet T. H. (ed.) Progress in Hemostasis and Thrombosis, Vol.1. New York: Grane and Stratton;